Gamma-Aminobutyric Acid (GABA) Receptor Market Report

Japan Gamma-Aminobutyric Acid (GABA) Receptor Market Professional Research Report 2014-2026, Segmented by Players, Types, End-Users in Major Region

  • POSTDATE：Jan 07, 2020
  • PAGES：191
  • REPORT CODE：GMM427091
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • This report offers an overview of the market trends, drivers, and barriers with respect to the Japan Gamma-Aminobutyric Acid (GABA) Receptor market. It also provides a detailed overview of the market of different regions across Hokkaido, Tohoku, Kanto, Chubu, Kinki, Chugoku, Shikoku, Kyushu. The report deep analyzes type and application in Japan Gamma-Aminobutyric Acid (GABA) Receptor market. Detailed analysis of key players, along with key growth strategies adopted by Gamma-Aminobutyric Acid (GABA) Receptor industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.

    By Player:

    • Osmotica Pharmaceutical

    • Pfizer

    • OVATION Pharmaceuticals

    • Biocodex

    • Novartis

    • Elan Corporation

    • VIVUS

    • Athena Drug Delivery Solutions

    • Advicenne

    • GlaxoSmithKline

    • sanofi-aventis

    • AstraZeneca

    • NovaDel Pharma

    • H.LundBeck

    • XenoPort

    • Eli Lilly & Company

    By Type:

    • GABAA

    • GABAB

    By End-User:

    • Attention Deficit Hyperactivity Disorder

    • Psychiatric Disorders

    • Alzheimer's Disease

    • Chronic Obstructive Pulmonary Disease

    • Memory Impairment

    • Other

    By Region:

    • Hokkaido

    • Tohoku

    • Kanto

    • Chubu

    • Kinki

    • Chugoku

    • Shikoku

    • Kyushu

  • 1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Gamma-Aminobutyric Acid (GABA) Receptor Market

    • 1.3 Market Segment by Type

      • 1.3.1 Japan Gamma-Aminobutyric Acid (GABA) Receptor Market Size and Growth Rate of GABAA from 2014 to 2026

      • 1.3.2 Japan Gamma-Aminobutyric Acid (GABA) Receptor Market Size and Growth Rate of GABAB from 2014 to 2026

    • 1.4 Market Segment by Application

      • 1.4.1 Japan Gamma-Aminobutyric Acid (GABA) Receptor Market Size and Growth Rate of Attention Deficit Hyperactivity Disorder from 2014 to 2026

      • 1.4.2 Japan Gamma-Aminobutyric Acid (GABA) Receptor Market Size and Growth Rate of Psychiatric Disorders from 2014 to 2026

      • 1.4.3 Japan Gamma-Aminobutyric Acid (GABA) Receptor Market Size and Growth Rate of Alzheimer's Disease from 2014 to 2026

      • 1.4.4 Japan Gamma-Aminobutyric Acid (GABA) Receptor Market Size and Growth Rate of Chronic Obstructive Pulmonary Disease from 2014 to 2026

      • 1.4.5 Japan Gamma-Aminobutyric Acid (GABA) Receptor Market Size and Growth Rate of Memory Impairment from 2014 to 2026

      • 1.4.6 Japan Gamma-Aminobutyric Acid (GABA) Receptor Market Size and Growth Rate of Other from 2014 to 2026

    • 1.5 Market Segment by Regions

      • 1.5.1 Hokkaido Gamma-Aminobutyric Acid (GABA) Receptor Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.2 Tohoku Gamma-Aminobutyric Acid (GABA) Receptor Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.3 Kanto Gamma-Aminobutyric Acid (GABA) Receptor Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.4 Chubu Gamma-Aminobutyric Acid (GABA) Receptor Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.5 Kinki Gamma-Aminobutyric Acid (GABA) Receptor Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.6 Chugoku Gamma-Aminobutyric Acid (GABA) Receptor Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.7 Shikoku Gamma-Aminobutyric Acid (GABA) Receptor Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.8 Kyushu Gamma-Aminobutyric Acid (GABA) Receptor Consumption Market Size and Growth Rate from 2014 to 2026

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    3 Segmentation of Gamma-Aminobutyric Acid (GABA) Receptor Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Commercial Products Types of Major Vendors

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Gamma-Aminobutyric Acid (GABA) Receptor by Major Types

      • 3.4.1 Market Size and Growth Rate of GABAA

      • 3.4.2 Market Size and Growth Rate of GABAB

    4 Segmentation of Gamma-Aminobutyric Acid (GABA) Receptor Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Gamma-Aminobutyric Acid (GABA) Receptor by Major End-Users

      • 4.4.1 Market Size and Growth Rate of Gamma-Aminobutyric Acid (GABA) Receptor in Attention Deficit Hyperactivity Disorder

      • 4.4.2 Market Size and Growth Rate of Gamma-Aminobutyric Acid (GABA) Receptor in Psychiatric Disorders

      • 4.4.3 Market Size and Growth Rate of Gamma-Aminobutyric Acid (GABA) Receptor in Alzheimer's Disease

      • 4.4.4 Market Size and Growth Rate of Gamma-Aminobutyric Acid (GABA) Receptor in Chronic Obstructive Pulmonary Disease

      • 4.4.5 Market Size and Growth Rate of Gamma-Aminobutyric Acid (GABA) Receptor in Memory Impairment

      • 4.4.6 Market Size and Growth Rate of Gamma-Aminobutyric Acid (GABA) Receptor in Other

    5 Market Analysis by Regions

    • 5.1 Japan Gamma-Aminobutyric Acid (GABA) Receptor Production Analysis by Regions

    • 5.2 Japan Gamma-Aminobutyric Acid (GABA) Receptor Consumption Analysis by Regions

    6 Hokkaido Gamma-Aminobutyric Acid (GABA) Receptor Landscape Analysis

    • 6.1 Hokkaido Gamma-Aminobutyric Acid (GABA) Receptor Landscape Analysis by Major Types

    • 6.2 Hokkaido Gamma-Aminobutyric Acid (GABA) Receptor Landscape Analysis by Major End-Users

    7 Tohoku Gamma-Aminobutyric Acid (GABA) Receptor Landscape Analysis

    • 7.1 Tohoku Gamma-Aminobutyric Acid (GABA) Receptor Landscape Analysis by Major Types

    • 7.2 Tohoku Gamma-Aminobutyric Acid (GABA) Receptor Landscape Analysis by Major End-Users

    8 Kanto Gamma-Aminobutyric Acid (GABA) Receptor Landscape Analysis

    • 8.1 Kanto Gamma-Aminobutyric Acid (GABA) Receptor Landscape Analysis by Major Types

    • 8.2 Kanto Gamma-Aminobutyric Acid (GABA) Receptor Landscape Analysis by Major End-Users

    9 Chubu Gamma-Aminobutyric Acid (GABA) Receptor Landscape Analysis

    • 9.1 Chubu Gamma-Aminobutyric Acid (GABA) Receptor Landscape Analysis by Major Types

    • 9.2 Chubu Gamma-Aminobutyric Acid (GABA) Receptor Landscape Analysis by Major End-Users

    10 Kinki Gamma-Aminobutyric Acid (GABA) Receptor Landscape Analysis

    • 10.1 Kinki Gamma-Aminobutyric Acid (GABA) Receptor Landscape Analysis by Major Types

    • 10.2 Kinki Gamma-Aminobutyric Acid (GABA) Receptor Landscape Analysis by Major End-Users

    11 Chugoku Gamma-Aminobutyric Acid (GABA) Receptor Landscape Analysis

    • 11.1 Chugoku Gamma-Aminobutyric Acid (GABA) Receptor Landscape Analysis by Major Types

    • 11.2 Chugoku Gamma-Aminobutyric Acid (GABA) Receptor Landscape Analysis by Major End-Users

    12 Shikoku Gamma-Aminobutyric Acid (GABA) Receptor Landscape Analysis

    • 12.1 Shikoku Gamma-Aminobutyric Acid (GABA) Receptor Landscape Analysis by Major Types

    • 12.2 Shikoku Gamma-Aminobutyric Acid (GABA) Receptor Landscape Analysis by Major End-Users

    13 Kyushu Gamma-Aminobutyric Acid (GABA) Receptor Landscape Analysis

    • 13.1 Kyushu Gamma-Aminobutyric Acid (GABA) Receptor Landscape Analysis by Major Types

    • 13.2 Kyushu Gamma-Aminobutyric Acid (GABA) Receptor Landscape Analysis by Major End-Users

    14 Major Players Profiles

    • 14.1 Osmotica Pharmaceutical

      • 14.1.1 Osmotica Pharmaceutical Company Profile and Recent Development

      • 14.1.2 Market Performance

      • 14.1.3 Product and Service Introduction

    • 14.2 Pfizer

      • 14.2.1 Pfizer Company Profile and Recent Development

      • 14.2.2 Market Performance

      • 14.2.3 Product and Service Introduction

    • 14.3 OVATION Pharmaceuticals

      • 14.3.1 OVATION Pharmaceuticals Company Profile and Recent Development

      • 14.3.2 Market Performance

      • 14.3.3 Product and Service Introduction

    • 14.4 Biocodex

      • 14.4.1 Biocodex Company Profile and Recent Development

      • 14.4.2 Market Performance

      • 14.4.3 Product and Service Introduction

    • 14.5 Novartis

      • 14.5.1 Novartis Company Profile and Recent Development

      • 14.5.2 Market Performance

      • 14.5.3 Product and Service Introduction

    • 14.6 Elan Corporation

      • 14.6.1 Elan Corporation Company Profile and Recent Development

      • 14.6.2 Market Performance

      • 14.6.3 Product and Service Introduction

    • 14.7 VIVUS

      • 14.7.1 VIVUS Company Profile and Recent Development

      • 14.7.2 Market Performance

      • 14.7.3 Product and Service Introduction

    • 14.8 Athena Drug Delivery Solutions

      • 14.8.1 Athena Drug Delivery Solutions Company Profile and Recent Development

      • 14.8.2 Market Performance

      • 14.8.3 Product and Service Introduction

    • 14.9 Advicenne

      • 14.9.1 Advicenne Company Profile and Recent Development

      • 14.9.2 Market Performance

      • 14.9.3 Product and Service Introduction

    • 14.10 GlaxoSmithKline

      • 14.10.1 GlaxoSmithKline Company Profile and Recent Development

      • 14.10.2 Market Performance

      • 14.10.3 Product and Service Introduction

    • 14.11 sanofi-aventis

      • 14.11.1 sanofi-aventis Company Profile and Recent Development

      • 14.11.2 Market Performance

      • 14.11.3 Product and Service Introduction

    • 14.12 AstraZeneca

      • 14.12.1 AstraZeneca Company Profile and Recent Development

      • 14.12.2 Market Performance

      • 14.12.3 Product and Service Introduction

    • 14.13 NovaDel Pharma

      • 14.13.1 NovaDel Pharma Company Profile and Recent Development

      • 14.13.2 Market Performance

      • 14.13.3 Product and Service Introduction

    • 14.14 H.LundBeck

      • 14.14.1 H.LundBeck Company Profile and Recent Development

      • 14.14.2 Market Performance

      • 14.14.3 Product and Service Introduction

    • 14.15 XenoPort

      • 14.15.1 XenoPort Company Profile and Recent Development

      • 14.15.2 Market Performance

      • 14.15.3 Product and Service Introduction

    • 14.16 Eli Lilly & Company

      • 14.16.1 Eli Lilly & Company Company Profile and Recent Development

      • 14.16.2 Market Performance

      • 14.16.3 Product and Service Introduction

     

    The List of Tables and Figures (Totals 122 Figures and 161 Tables)

    • Figure Japan Gamma-Aminobutyric Acid (GABA) Receptor Market Size and Growth Rate of GABAA from 2014 to 2026

    • Figure Japan Gamma-Aminobutyric Acid (GABA) Receptor Market Size and Growth Rate of GABAB from 2014 to 2026

    • Figure Market Share by Type in 2014

    • Figure Market Share by Type in 2018

    • Figure Market Share by Type in 2026

    • Figure Japan Gamma-Aminobutyric Acid (GABA) Receptor Market Size and Growth Rate of Attention Deficit Hyperactivity Disorder from 2014 to 2026

    • Figure Japan Gamma-Aminobutyric Acid (GABA) Receptor Market Size and Growth Rate of Psychiatric Disorders from 2014 to 2026

    • Figure Japan Gamma-Aminobutyric Acid (GABA) Receptor Market Size and Growth Rate of Alzheimer's Disease from 2014 to 2026

    • Figure Japan Gamma-Aminobutyric Acid (GABA) Receptor Market Size and Growth Rate of Chronic Obstructive Pulmonary Disease from 2014 to 2026

    • Figure Japan Gamma-Aminobutyric Acid (GABA) Receptor Market Size and Growth Rate of Memory Impairment from 2014 to 2026

    • Figure Japan Gamma-Aminobutyric Acid (GABA) Receptor Market Size and Growth Rate of Other from 2014 to 2026

    • Figure Market Share by End-User in 2014

    • Figure Market Share by End-User in 2018

    • Figure Market Share by End-User in 2026

    • Figure Hokkaido Gamma-Aminobutyric Acid (GABA) Receptor Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Tohoku Gamma-Aminobutyric Acid (GABA) Receptor Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Kanto Gamma-Aminobutyric Acid (GABA) Receptor Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Chubu Gamma-Aminobutyric Acid (GABA) Receptor Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Kinki Gamma-Aminobutyric Acid (GABA) Receptor Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Chugoku Gamma-Aminobutyric Acid (GABA) Receptor Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Shikoku Gamma-Aminobutyric Acid (GABA) Receptor Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Kyushu Gamma-Aminobutyric Acid (GABA) Receptor Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Development Trends and Industry Dynamics of Gamma-Aminobutyric Acid (GABA) Receptor Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 3 Players in 2018

    • Figure Market Share of TOP 5 Players in 2018

    • Figure Market Share of TOP 6 Players from 2014 to 2019

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Table Specifications of Different Types of Gamma-Aminobutyric Acid (GABA) Receptor

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Gamma-Aminobutyric Acid (GABA) Receptor by Different Types from 2014 to 2026

    • Table Consumption Share of Gamma-Aminobutyric Acid (GABA) Receptor by Different Types from 2014 to 2026

    • Figure Market Size and Growth Rate of GABAA

    • Figure Market Size and Growth Rate of GABAB

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Table Consumption of Gamma-Aminobutyric Acid (GABA) Receptor by Different End-Users from 2014 to 2026

    • Table Consumption Share of Gamma-Aminobutyric Acid (GABA) Receptor by Different End-Users from 2014 to 2026

    • Figure Japan Gamma-Aminobutyric Acid (GABA) Receptor Market Size and Growth Rate of Attention Deficit Hyperactivity Disorder from 2014 to 2026

    • Figure Japan Gamma-Aminobutyric Acid (GABA) Receptor Market Size and Growth Rate of Psychiatric Disorders from 2014 to 2026

    • Figure Japan Gamma-Aminobutyric Acid (GABA) Receptor Market Size and Growth Rate of Alzheimer's Disease from 2014 to 2026

    • Figure Japan Gamma-Aminobutyric Acid (GABA) Receptor Market Size and Growth Rate of Chronic Obstructive Pulmonary Disease from 2014 to 2026

    • Figure Japan Gamma-Aminobutyric Acid (GABA) Receptor Market Size and Growth Rate of Memory Impairment from 2014 to 2026

    • Figure Japan Gamma-Aminobutyric Acid (GABA) Receptor Market Size and Growth Rate of Other from 2014 to 2026

    • Table Japan Gamma-Aminobutyric Acid (GABA) Receptor Production by Regions

    • Table Japan Gamma-Aminobutyric Acid (GABA) Receptor Production Share by Regions

    • Figure Japan Gamma-Aminobutyric Acid (GABA) Receptor Production Share by Regions in 2014

    • Figure Japan Gamma-Aminobutyric Acid (GABA) Receptor Production Share by Regions in 2018

    • Figure Japan Gamma-Aminobutyric Acid (GABA) Receptor Production Share by Regions in 2026

    • Table Japan Gamma-Aminobutyric Acid (GABA) Receptor Consumption by Regions

    • Table Japan Gamma-Aminobutyric Acid (GABA) Receptor Consumption Share by Regions

    • Figure Japan Gamma-Aminobutyric Acid (GABA) Receptor Consumption Share by Regions in 2014

    • Figure Japan Gamma-Aminobutyric Acid (GABA) Receptor Consumption Share by Regions in 2018

    • Figure Japan Gamma-Aminobutyric Acid (GABA) Receptor Consumption Share by Regions in 2026

    • Table Hokkaido Gamma-Aminobutyric Acid (GABA) Receptor Consumption by Types from 2014 to 2026

    • Table Hokkaido Gamma-Aminobutyric Acid (GABA) Receptor Consumption Share by Types from 2014 to 2026

    • Figure Hokkaido Gamma-Aminobutyric Acid (GABA) Receptor Consumption Share by Types in 2014

    • Figure Hokkaido Gamma-Aminobutyric Acid (GABA) Receptor Consumption Share by Types in 2018

    • Figure Hokkaido Gamma-Aminobutyric Acid (GABA) Receptor Consumption Share by Types in 2026

    • Table Hokkaido Gamma-Aminobutyric Acid (GABA) Receptor Consumption by End-Users from 2014 to 2026

    • Table Hokkaido Gamma-Aminobutyric Acid (GABA) Receptor Consumption Share by End-Users from 2014 to 2026

    • Figure Hokkaido Gamma-Aminobutyric Acid (GABA) Receptor Consumption Share by End-Users in 2014

    • Figure Hokkaido Gamma-Aminobutyric Acid (GABA) Receptor Consumption Share by End-Users in 2018

    • Figure Hokkaido Gamma-Aminobutyric Acid (GABA) Receptor Consumption Share by End-Users in 2026

    • Table Tohoku Gamma-Aminobutyric Acid (GABA) Receptor Consumption by Types from 2014 to 2026

    • Table Tohoku Gamma-Aminobutyric Acid (GABA) Receptor Consumption Share by Types from 2014 to 2026

    • Figure Tohoku Gamma-Aminobutyric Acid (GABA) Receptor Consumption Share by Types in 2014

    • Figure Tohoku Gamma-Aminobutyric Acid (GABA) Receptor Consumption Share by Types in 2018

    • Figure Tohoku Gamma-Aminobutyric Acid (GABA) Receptor Consumption Share by Types in 2026

    • Table Tohoku Gamma-Aminobutyric Acid (GABA) Receptor Consumption by End-Users from 2014 to 2026

    • Table Tohoku Gamma-Aminobutyric Acid (GABA) Receptor Consumption Share by End-Users from 2014 to 2026

    • Figure Tohoku Gamma-Aminobutyric Acid (GABA) Receptor Consumption Share by End-Users in 2014

    • Figure Tohoku Gamma-Aminobutyric Acid (GABA) Receptor Consumption Share by End-Users in 2018

    • Figure Tohoku Gamma-Aminobutyric Acid (GABA) Receptor Consumption Share by End-Users in 2026

    • Table Kanto Gamma-Aminobutyric Acid (GABA) Receptor Consumption by Types from 2014 to 2026

    • Table Kanto Gamma-Aminobutyric Acid (GABA) Receptor Consumption Share by Types from 2014 to 2026

    • Figure Kanto Gamma-Aminobutyric Acid (GABA) Receptor Consumption Share by Types in 2014

    • Figure Kanto Gamma-Aminobutyric Acid (GABA) Receptor Consumption Share by Types in 2018

    • Figure Kanto Gamma-Aminobutyric Acid (GABA) Receptor Consumption Share by Types in 2026

    • Table Kanto Gamma-Aminobutyric Acid (GABA) Receptor Consumption by End-Users from 2014 to 2026

    • Table Kanto Gamma-Aminobutyric Acid (GABA) Receptor Consumption Share by End-Users from 2014 to 2026

    • Figure Kanto Gamma-Aminobutyric Acid (GABA) Receptor Consumption Share by End-Users in 2014

    • Figure Kanto Gamma-Aminobutyric Acid (GABA) Receptor Consumption Share by End-Users in 2018

    • Figure Kanto Gamma-Aminobutyric Acid (GABA) Receptor Consumption Share by End-Users in 2026

    • Table Chubu Gamma-Aminobutyric Acid (GABA) Receptor Consumption by Types from 2014 to 2026

    • Table Chubu Gamma-Aminobutyric Acid (GABA) Receptor Consumption Share by Types from 2014 to 2026

    • Figure Chubu Gamma-Aminobutyric Acid (GABA) Receptor Consumption Share by Types in 2014

    • Figure Chubu Gamma-Aminobutyric Acid (GABA) Receptor Consumption Share by Types in 2018

    • Figure Chubu Gamma-Aminobutyric Acid (GABA) Receptor Consumption Share by Types in 2026

    • Table Chubu Gamma-Aminobutyric Acid (GABA) Receptor Consumption by End-Users from 2014 to 2026

    • Table Chubu Gamma-Aminobutyric Acid (GABA) Receptor Consumption Share by End-Users from 2014 to 2026

    • Figure Chubu Gamma-Aminobutyric Acid (GABA) Receptor Consumption Share by End-Users in 2014

    • Figure Chubu Gamma-Aminobutyric Acid (GABA) Receptor Consumption Share by End-Users in 2018

    • Figure Chubu Gamma-Aminobutyric Acid (GABA) Receptor Consumption Share by End-Users in 2026

    • Table Kinki Gamma-Aminobutyric Acid (GABA) Receptor Consumption by Types from 2014 to 2026

    • Table Kinki Gamma-Aminobutyric Acid (GABA) Receptor Consumption Share by Types from 2014 to 2026

    • Figure Kinki Gamma-Aminobutyric Acid (GABA) Receptor Consumption Share by Types in 2014

    • Figure Kinki Gamma-Aminobutyric Acid (GABA) Receptor Consumption Share by Types in 2018

    • Figure Kinki Gamma-Aminobutyric Acid (GABA) Receptor Consumption Share by Types in 2026

    • Table Kinki Gamma-Aminobutyric Acid (GABA) Receptor Consumption by End-Users from 2014 to 2026

    • Table Kinki Gamma-Aminobutyric Acid (GABA) Receptor Consumption Share by End-Users from 2014 to 2026

    • Figure Kinki Gamma-Aminobutyric Acid (GABA) Receptor Consumption Share by End-Users in 2014

    • Figure Kinki Gamma-Aminobutyric Acid (GABA) Receptor Consumption Share by End-Users in 2018

    • Figure Kinki Gamma-Aminobutyric Acid (GABA) Receptor Consumption Share by End-Users in 2026

    • Table Chugoku Gamma-Aminobutyric Acid (GABA) Receptor Consumption by Types from 2014 to 2026

    • Table Chugoku Gamma-Aminobutyric Acid (GABA) Receptor Consumption Share by Types from 2014 to 2026

    • Figure Chugoku Gamma-Aminobutyric Acid (GABA) Receptor Consumption Share by Types in 2014

    • Figure Chugoku Gamma-Aminobutyric Acid (GABA) Receptor Consumption Share by Types in 2018

    • Figure Chugoku Gamma-Aminobutyric Acid (GABA) Receptor Consumption Share by Types in 2026

    • Table Chugoku Gamma-Aminobutyric Acid (GABA) Receptor Consumption by End-Users from 2014 to 2026

    • Table Chugoku Gamma-Aminobutyric Acid (GABA) Receptor Consumption Share by End-Users from 2014 to 2026

    • Figure Chugoku Gamma-Aminobutyric Acid (GABA) Receptor Consumption Share by End-Users in 2014

    • Figure Chugoku Gamma-Aminobutyric Acid (GABA) Receptor Consumption Share by End-Users in 2018

    • Figure Chugoku Gamma-Aminobutyric Acid (GABA) Receptor Consumption Share by End-Users in 2026

    • Table Shikoku Gamma-Aminobutyric Acid (GABA) Receptor Consumption by Types from 2014 to 2026

    • Table Shikoku Gamma-Aminobutyric Acid (GABA) Receptor Consumption Share by Types from 2014 to 2026

    • Figure Shikoku Gamma-Aminobutyric Acid (GABA) Receptor Consumption Share by Types in 2014

    • Figure Shikoku Gamma-Aminobutyric Acid (GABA) Receptor Consumption Share by Types in 2018

    • Figure Shikoku Gamma-Aminobutyric Acid (GABA) Receptor Consumption Share by Types in 2026

    • Table Shikoku Gamma-Aminobutyric Acid (GABA) Receptor Consumption by End-Users from 2014 to 2026

    • Table Shikoku Gamma-Aminobutyric Acid (GABA) Receptor Consumption Share by End-Users from 2014 to 2026

    • Figure Shikoku Gamma-Aminobutyric Acid (GABA) Receptor Consumption Share by End-Users in 2014

    • Figure Shikoku Gamma-Aminobutyric Acid (GABA) Receptor Consumption Share by End-Users in 2018

    • Figure Shikoku Gamma-Aminobutyric Acid (GABA) Receptor Consumption Share by End-Users in 2026

    • Table Kyushu Gamma-Aminobutyric Acid (GABA) Receptor Consumption by Types from 2014 to 2026

    • Table Kyushu Gamma-Aminobutyric Acid (GABA) Receptor Consumption Share by Types from 2014 to 2026

    • Figure Kyushu Gamma-Aminobutyric Acid (GABA) Receptor Consumption Share by Types in 2014

    • Figure Kyushu Gamma-Aminobutyric Acid (GABA) Receptor Consumption Share by Types in 2018

    • Figure Kyushu Gamma-Aminobutyric Acid (GABA) Receptor Consumption Share by Types in 2026

    • Table Kyushu Gamma-Aminobutyric Acid (GABA) Receptor Consumption by End-Users from 2014 to 2026

    • Table Kyushu Gamma-Aminobutyric Acid (GABA) Receptor Consumption Share by End-Users from 2014 to 2026

    • Figure Kyushu Gamma-Aminobutyric Acid (GABA) Receptor Consumption Share by End-Users in 2014

    • Figure Kyushu Gamma-Aminobutyric Acid (GABA) Receptor Consumption Share by End-Users in 2018

    • Figure Kyushu Gamma-Aminobutyric Acid (GABA) Receptor Consumption Share by End-Users in 2026

    • Table Company Profile and Development Status of Osmotica Pharmaceutical

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Osmotica Pharmaceutical

    • Figure Sales and Growth Rate Analysis of Osmotica Pharmaceutical

    • Figure Revenue and Market Share Analysis of Osmotica Pharmaceutical

    • Table Product and Service Introduction of Osmotica Pharmaceutical

    • Table Company Profile and Development Status of Pfizer

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Pfizer

    • Figure Sales and Growth Rate Analysis of Pfizer

    • Figure Revenue and Market Share Analysis of Pfizer

    • Table Product and Service Introduction of Pfizer

    • Table Company Profile and Development Status of OVATION Pharmaceuticals

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of OVATION Pharmaceuticals

    • Figure Sales and Growth Rate Analysis of OVATION Pharmaceuticals

    • Figure Revenue and Market Share Analysis of OVATION Pharmaceuticals

    • Table Product and Service Introduction of OVATION Pharmaceuticals

    • Table Company Profile and Development Status of Biocodex

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Biocodex

    • Figure Sales and Growth Rate Analysis of Biocodex

    • Figure Revenue and Market Share Analysis of Biocodex

    • Table Product and Service Introduction of Biocodex

    • Table Company Profile and Development Status of Novartis

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Novartis

    • Figure Sales and Growth Rate Analysis of Novartis

    • Figure Revenue and Market Share Analysis of Novartis

    • Table Product and Service Introduction of Novartis

    • Table Company Profile and Development Status of Elan Corporation

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Elan Corporation

    • Figure Sales and Growth Rate Analysis of Elan Corporation

    • Figure Revenue and Market Share Analysis of Elan Corporation

    • Table Product and Service Introduction of Elan Corporation

    • Table Company Profile and Development Status of VIVUS

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of VIVUS

    • Figure Sales and Growth Rate Analysis of VIVUS

    • Figure Revenue and Market Share Analysis of VIVUS

    • Table Product and Service Introduction of VIVUS

    • Table Company Profile and Development Status of Athena Drug Delivery Solutions

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Athena Drug Delivery Solutions

    • Figure Sales and Growth Rate Analysis of Athena Drug Delivery Solutions

    • Figure Revenue and Market Share Analysis of Athena Drug Delivery Solutions

    • Table Product and Service Introduction of Athena Drug Delivery Solutions

    • Table Company Profile and Development Status of Advicenne

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Advicenne

    • Figure Sales and Growth Rate Analysis of Advicenne

    • Figure Revenue and Market Share Analysis of Advicenne

    • Table Product and Service Introduction of Advicenne

    • Table Company Profile and Development Status of GlaxoSmithKline

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of GlaxoSmithKline

    • Figure Sales and Growth Rate Analysis of GlaxoSmithKline

    • Figure Revenue and Market Share Analysis of GlaxoSmithKline

    • Table Product and Service Introduction of GlaxoSmithKline

    • Table Company Profile and Development Status of sanofi-aventis

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of sanofi-aventis

    • Figure Sales and Growth Rate Analysis of sanofi-aventis

    • Figure Revenue and Market Share Analysis of sanofi-aventis

    • Table Product and Service Introduction of sanofi-aventis

    • Table Company Profile and Development Status of AstraZeneca

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of AstraZeneca

    • Figure Sales and Growth Rate Analysis of AstraZeneca

    • Figure Revenue and Market Share Analysis of AstraZeneca

    • Table Product and Service Introduction of AstraZeneca

    • Table Company Profile and Development Status of NovaDel Pharma

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of NovaDel Pharma

    • Figure Sales and Growth Rate Analysis of NovaDel Pharma

    • Figure Revenue and Market Share Analysis of NovaDel Pharma

    • Table Product and Service Introduction of NovaDel Pharma

    • Table Company Profile and Development Status of H.LundBeck

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of H.LundBeck

    • Figure Sales and Growth Rate Analysis of H.LundBeck

    • Figure Revenue and Market Share Analysis of H.LundBeck

    • Table Product and Service Introduction of H.LundBeck

    • Table Company Profile and Development Status of XenoPort

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of XenoPort

    • Figure Sales and Growth Rate Analysis of XenoPort

    • Figure Revenue and Market Share Analysis of XenoPort

    • Table Product and Service Introduction of XenoPort

    • Table Company Profile and Development Status of Eli Lilly & Company

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Eli Lilly & Company

    • Figure Sales and Growth Rate Analysis of Eli Lilly & Company

    • Figure Revenue and Market Share Analysis of Eli Lilly & Company

    • Table Product and Service Introduction of Eli Lilly & Company

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US